News
IDIBELL, re-accredited as a health research institute by the Institute of Health Carlos III
This re-accreditation complements the one obtained from CERCA at the beginning of the year
SeptiLoop receives € 100,000 to develop a rapid diagnostic kit for sepsis
The IDIBELL and Bellvitge University Hospital researcher Joan Sabater, in collaboration with the Loop Dx start-up, of the Center for the Integration of Medicine and Innovative Technologies (CIMTI), has obtained € 100,000 of funding from the aid Product of the AGAUR agency of the Government of Catalonia. These aids are used to obtain prototypes and […]
[Statement] Finalisation of IDIBELL’s Epigenetics and Cancer Biology Program
The Bellvitge Biomedical Research Institute (IDIBELL) would like to state that, in accordance with the new responsibility of Dr Manel Esteller as director of the Josep Carreras Leukaemia Research Institute (IJC), the Cancer Epigenetics and Biology Program (PEBC) that he has led at IDIBELL so far has been discontinued. IDIBELL research groups led by Dr Montserrat Sanchez-Cespedes, Dr Àlex Vaquero, […]
IDIBELL celebrates 15 years
The Bellvitge Biomedical Research Institute commemorates its 15 years of existence evaluating its past and facing the future with optimism
Raúl Zamora wins the 2nd edition of the Jesús Serra Foundation Research Awards
The researcher Raúl Zamora Ros, from the Bellvitge Biomedical Research Institute (IDIBELL) and the Catalan Institute of Oncology (ICO), has been chosen by the jury of the Jesús Serra Foundation Research Awards as the winner in the clinical research category. This award is aimed at scientists below 45 years old specialized in nutrition, food and […]
Fluorescent dopaminergic neurons to accelerate Parkinson’s disease research
A team of scientists led by Dr. Antonella Consiglio from the IDIBELL and the University of Barcelona (UB), and Dr. Angel Raya from the Center of Regenerative Medicine of Barcelona (CMR[B]/IDIBELL) reveal in Scientific Reports today an efficient and new method for generating fluorescently-labeled dopaminergic neurons (DAn), a specific cell type that die in Parkinson’s […]
The new Program for Regenerative Medicine in Catalonia has officially launched
IDIBELL and CMR[B] join efforts for the new Clinical Translational Program for Regenerative Medicine in Catalonia (P-CMR[C]), presented in an event chaired by the president of the Generalitat
IDIBELL – ICO researchers set new bases to develop therapies against colorectal cancer
The discovery is based on targeting the tissue surrounding the tumor, instead of the tumor directly